These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6236679)
1. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Barnett A; Iorio LC; Kreutner W; Tozzi S; Ahn HS; Gulbenkian A Agents Actions; 1984 Jun; 14(5-6):590-7. PubMed ID: 6236679 [TBL] [Abstract][Full Text] [Related]
2. N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability. Villani FJ; Magatti CV; Vashi DB; Wong J; Popper TL Arzneimittelforschung; 1986 Sep; 36(9):1311-4. PubMed ID: 2947582 [TBL] [Abstract][Full Text] [Related]
3. Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine. Ahn HS; Barnett A Eur J Pharmacol; 1986 Aug; 127(1-2):153-5. PubMed ID: 2875889 [TBL] [Abstract][Full Text] [Related]
4. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs. Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569 [TBL] [Abstract][Full Text] [Related]
5. Interaction studies in mice of SCH 29851, a potential non-sedating antihistamine, with commonly used therapeutic agents. Iorio LC; Cohen-Winston M; Barnett A Agents Actions; 1986 Aug; 18(5-6):485-93. PubMed ID: 2945410 [TBL] [Abstract][Full Text] [Related]
6. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine. Billah MM; Chapman RW; Egan RW; Gilchrest H; Piwinski JJ; Sherwood J; Siegel MI; West RE; Kreutner W J Pharmacol Exp Ther; 1990 Mar; 252(3):1090-6. PubMed ID: 2319461 [TBL] [Abstract][Full Text] [Related]
7. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor. Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365 [TBL] [Abstract][Full Text] [Related]
8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
9. Variations among non-sedating antihistamines: are there real differences? Mattila MJ; Paakkari I Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901 [TBL] [Abstract][Full Text] [Related]
10. Preclinical comparison of ebastine and other second generation H1-antihistamines. Yakuo I; Yabuuchi M; Ito T Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966 [TBL] [Abstract][Full Text] [Related]
11. Antiallergic activity of loratadine, a non-sedating antihistamine. Kreutner W; Chapman RW; Gulbenkian A; Siegel MI Allergy; 1987 Jan; 42(1):57-63. PubMed ID: 2436504 [TBL] [Abstract][Full Text] [Related]
12. Antitussive action of antihistamines is independent of sedative and ventilation activity in the guinea pig. McLeod RL; Mingo G; O'Reilly S; Ruck LA; Bolser DC; Hey JA Pharmacology; 1998 Aug; 57(2):57-64. PubMed ID: 9691225 [TBL] [Abstract][Full Text] [Related]
13. Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. Billah MM; Chapman RW; Watnick AS; Egan RW; Siegel MI; Kreutner W Agents Actions Suppl; 1991; 34():313-21. PubMed ID: 1793070 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
15. Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat. Marzanatti M; Monopoli A; Trampus M; Ongini E Pharmacol Biochem Behav; 1989 Apr; 32(4):861-6. PubMed ID: 2572005 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of the new H1-receptor antagonist setastine hydrochloride. Porszász J; Varga F; Porszász KG; Szolscányi J; Barthó L; Petöcz L; Kápolnai L Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625 [TBL] [Abstract][Full Text] [Related]
18. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine. Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244 [TBL] [Abstract][Full Text] [Related]